Piyush Mehta - 12 Sep 2025 Form 4 Insider Report for Genpact LTD (G)

Role
Senior Vice President and CHRO
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Piyush Mehta
Issuer symbol
G
Transactions as of
12 Sep 2025
Transactions value $
-$1,699,487
Form type
4
Filing time
15 Sep 2025, 16:36:06 UTC
Previous filing
13 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mehta Piyush Senior Vice President and CHRO C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK /s/ Thomas D. Scholtes, as Attorney-in-fact for Piyush Mehta 15 Sep 2025 0001408238

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $1.58M +50K +30.91% $31.50 212K 12 Sep 2025 Direct F1
transaction G Common Shares Sale -$2.13M -50K -23.61% $42.58 162K 12 Sep 2025 Direct F2
transaction G Common Shares Sale -$1.15M -26.9K -16.63% $42.58 135K 12 Sep 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50K -100% $0.00 0 12 Sep 2025 Common Shares 50K $31.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 284 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 10,222 shares under the ESPP.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The option vested 50% on April 2, 2021 and the remainder on April 2, 2023.